This guidance has been developed for healthcare professionals managing heart failure symptoms when end of life is expected within weeks to days. For these patients it would likely be inappropriate to monitor bloods at this stage of a patient’s illness. However due to the trajectory of heart failure it is advised to use clinical judgement to monitor bloods or vital observations should the end of life stage become prolonged or longer than predicted.